Home › Companies › Clover Health Investments, Corp. › 2025-2026
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and Clover Health Investments, Corp.’s Form 8-K, filed June 12, 2026 (Item 5.07 on EDGAR). Page generated November 20, 2026.
Meeting of June 10, 2026: 5 items on Clover Health Investments, Corp.’s Form 8-K, filed June 12, 2026: 3 elected · 1 approved · 1 passed (calculated).
No notable dissent.
Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided
Explore Clover Health Investments, Corp. in the interactive database Compare manager voting policies
These tallies are Clover Health Investments, Corp.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 12, 2026 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Demetrios L. Kouzoukas | 1,003,131,251 | -- | -- | 11,409,888 | 177,790,033 | 99% | Elected | — |
| Elect Director: Andrew Toy | 1,011,117,814 | -- | -- | 3,423,325 | 177,790,033 | 99.7% | Elected | — |
| Elect Director: Thomas L. Tran | 996,918,879 | -- | -- | 17,622,260 | 177,790,033 | 98% | Elected | — |
| 2. Non-binding advisory vote to approve the compensation of the Company's Named Executive Officers for 2025 | 1,003,065,402 | 9,811,825 | 1,663,812 | -- | 177,790,033 | 99.0% | Passed (calculated) | — |
| 3. Ratification of the appointment of Ernst & Young LLP as independent registered public accounting firm for the fiscal year ending December 31, 2026 | 1,188,467,663 | 2,471,606 | 1,391,903 | -- | -- | 99.8% | Approved | — |
Source: Clover Health Investments, Corp., Form 8-K, filed with the SEC on June 12, 2026 — read the filing on EDGAR.
See voting trends for Health Care companies, 2025-2026: shareholder support by sector and by company size.
163 asset managers disclosed a vote on at least one Clover Health Investments, Corp. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 5 wordings of this item as funds reported it.
99.7% Majority: yes · of votes cast
Description as filed by funds: ELECTION OF DIRECTORS: Andrew Toy
Clover Health Investments, Corp.’s own tally for this item (“Elect Director: Andrew Toy”): 1,011,117,814 for, 3,423,325 withheld, per its Form 8-K filed June 12, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Demetrios L. Kouzoukas, Andrew Toy and Thomas L. Tran were each elected to the Company's Board of Directors as Class II directors, to serve until the 2029 annual meeting of stockholders and until their successors are duly elected and qualified.”
Support: 99.7% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 44 asset managers below reported 33,251,658 for, 159,058 withheld, 39,386 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 20,478,885 | 0 | 35 | 37,761 | For |
| Charles Schwab | 5,306,421 | 0 | 0 | 0 | For |
| BlackRock | 2,548,826 | 0 | 0 | 0 | For |
| Fidelity | 1,175,087 | 0 | 0 | 0 | For |
| Equitable | 832,293 | 0 | 0 | 0 | For |
| TIAA | 733,924 | 0 | 0 | 0 | For |
| Lincoln Financial | 526,054 | 0 | 0 | 0 | For |
| Global X | 335,678 | 0 | 0 | 0 | For |
| Northern Trust | 182,989 | 0 | 0 | 0 | For |
| State Street | 159,775 | 0 | 0 | 29 | For |
| JPMorgan | 145,408 | 0 | 0 | 0 | For |
| Pacific Life | 138,183 | 0 | 0 | 0 | For |
| Lazard | 100,917 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 0 | 79,573 | Withhold |
| Bridge Builder Trust | 78,341 | 0 | 0 | 0 | For |
| SEI | 60,200 | 0 | 0 | 0 | For |
| DWS | 56,976 | 0 | 0 | 0 | For |
| ProShares | 45,515 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 45,316 | 0 | 0 | 0 | For |
| T. Rowe Price | 40,735 | 0 | 0 | 0 | For |
| Jackson National | 0 | 0 | 39,351 | 0 | Abstain |
| John Hancock | 38,986 | 0 | 0 | 0 | For |
| Voya | 0 | 0 | 0 | 35,519 | Withhold |
| Calvert | 33,733 | 0 | 0 | 0 | For |
| Federated Hermes | 32,750 | 0 | 0 | 0 | For |
Showing the 25 largest of 44 asset managers. All 44 are in the interactive database (link above).
Combines 5 wordings of this item as funds reported it.
99% Majority: yes · of votes cast
Description as filed by funds: ELECTION OF DIRECTORS: Demetrios L. Kouzoukas
Clover Health Investments, Corp.’s own tally for this item (“Elect Director: Demetrios L. Kouzoukas”): 1,003,131,251 for, 11,409,888 withheld, per its Form 8-K filed June 12, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Demetrios L. Kouzoukas, Andrew Toy and Thomas L. Tran were each elected to the Company's Board of Directors as Class II directors, to serve until the 2029 annual meeting of stockholders and until their successors are duly elected and qualified.”
Support: 99% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 44 asset managers below reported 31,384,500 for, 1,987,147 withheld, 78,455 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 20,478,802 | 0 | 118 | 37,761 | For |
| Charles Schwab | 5,306,421 | 0 | 0 | 0 | For |
| BlackRock | 2,548,826 | 0 | 0 | 0 | For |
| Fidelity | 1,175,087 | 0 | 0 | 0 | For |
| Equitable | 832,293 | 0 | 0 | 0 | For |
| TIAA | 0 | 0 | 0 | 733,924 | Withhold |
| Lincoln Financial | 0 | 0 | 0 | 526,054 | Withhold |
| Global X | 335,678 | 0 | 0 | 0 | For |
| Northern Trust | 182,989 | 0 | 0 | 0 | For |
| State Street | 154 | 0 | 0 | 159,650 | Withhold |
| JPMorgan | 145,408 | 0 | 0 | 0 | For |
| Pacific Life | 138,183 | 0 | 0 | 0 | For |
| Lazard | 0 | 0 | 0 | 100,917 | Withhold |
| Dimensional | 0 | 0 | 0 | 79,573 | Withhold |
| Bridge Builder Trust | 78,341 | 0 | 0 | 0 | For |
| SEI | 60,200 | 0 | 0 | 0 | For |
| DWS | 0 | 0 | 0 | 56,976 | Withhold |
| ProShares | 0 | 0 | 0 | 45,515 | Withhold |
| AIG/SunAmerica | 0 | 0 | 0 | 45,316 | Withhold |
| T. Rowe Price | 0 | 0 | 0 | 40,735 | Withhold |
| Jackson National | 0 | 0 | 39,351 | 0 | Abstain |
| John Hancock | 0 | 0 | 38,986 | 0 | Abstain |
| Voya | 0 | 0 | 0 | 35,519 | Withhold |
| Calvert | 0 | 0 | 0 | 33,733 | Withhold |
| Federated Hermes | 32,750 | 0 | 0 | 0 | For |
Showing the 25 largest of 44 asset managers. All 44 are in the interactive database (link above).
Combines 5 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Description as filed by funds: ELECTION OF DIRECTORS: Thomas L. Tran
Clover Health Investments, Corp.’s own tally for this item (“Elect Director: Thomas L. Tran”): 996,918,879 for, 17,622,260 withheld, per its Form 8-K filed June 12, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Demetrios L. Kouzoukas, Andrew Toy and Thomas L. Tran were each elected to the Company's Board of Directors as Class II directors, to serve until the 2029 annual meeting of stockholders and until their successors are duly elected and qualified.”
Support: 98% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 44 asset managers below reported 25,479,280 for, 7,892,321 withheld, 78,501 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 20,498,191 | 0 | 164 | 18,326 | For |
| Charles Schwab | 0 | 0 | 0 | 5,306,421 | Withhold |
| BlackRock | 2,548,826 | 0 | 0 | 0 | For |
| Fidelity | 236,817 | 0 | 0 | 938,270 | Mixed |
| Equitable | 568,393 | 0 | 0 | 263,900 | Mixed |
| TIAA | 733,924 | 0 | 0 | 0 | For |
| Lincoln Financial | 278,200 | 0 | 0 | 247,854 | Mixed |
| Global X | 0 | 0 | 0 | 335,678 | Withhold |
| Northern Trust | 0 | 0 | 0 | 182,989 | Withhold |
| State Street | 159,383 | 0 | 0 | 421 | For |
| JPMorgan | 145,408 | 0 | 0 | 0 | For |
| Pacific Life | 138,183 | 0 | 0 | 0 | For |
| Lazard | 0 | 0 | 0 | 100,917 | Withhold |
| Dimensional | 0 | 0 | 0 | 79,573 | Withhold |
| Bridge Builder Trust | 78,341 | 0 | 0 | 0 | For |
| SEI | 0 | 0 | 0 | 60,200 | Withhold |
| DWS | 0 | 0 | 0 | 56,976 | Withhold |
| ProShares | 0 | 0 | 0 | 45,515 | Withhold |
| AIG/SunAmerica | 0 | 0 | 0 | 45,316 | Withhold |
| T. Rowe Price | 0 | 0 | 0 | 40,735 | Withhold |
| Jackson National | 0 | 0 | 39,351 | 0 | Abstain |
| John Hancock | 0 | 0 | 38,986 | 0 | Abstain |
| Voya | 0 | 0 | 0 | 35,519 | Withhold |
| Calvert | 0 | 0 | 0 | 33,733 | Withhold |
| Federated Hermes | 32,750 | 0 | 0 | 0 | For |
Showing the 25 largest of 44 asset managers. All 44 are in the interactive database (link above).
Combines 9 wordings of this item as funds reported it.
99.0% Majority: yes · of votes cast
Prior year: 99.4% for (June 10, 2025 meeting) ▼ 0.3 pts
Description as filed by funds: Non-binding advisory proposal to approve the compensation paid to our named executive officers for 2025.
Clover Health Investments, Corp.’s own tally for this item (“2. Non-binding advisory vote to approve the compensation of the Company's Named Executive Officers for 2025”): 1,003,065,402 for, 9,811,825 against, per its Form 8-K filed June 12, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99.0% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 20,516,565 | 101 | 17 | 0 | For |
| Charles Schwab | 5,306,421 | 0 | 0 | 0 | For |
| BlackRock | 2,548,826 | 0 | 0 | 0 | For |
| Fidelity | 1,175,087 | 0 | 0 | 0 | For |
| Equitable | 832,293 | 0 | 0 | 0 | For |
| TIAA | 733,924 | 0 | 0 | 0 | For |
| Lincoln Financial | 526,054 | 0 | 0 | 0 | For |
| Global X | 335,678 | 0 | 0 | 0 | For |
| Northern Trust | 182,989 | 0 | 0 | 0 | For |
| State Street | 159,804 | 0 | 0 | 0 | For |
| JPMorgan | 145,408 | 0 | 0 | 0 | For |
| Pacific Life | 138,183 | 0 | 0 | 0 | For |
| Lazard | 100,917 | 0 | 0 | 0 | For |
| Dimensional | 79,573 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 78,341 | 0 | 0 | 0 | For |
| SEI | 60,200 | 0 | 0 | 0 | For |
| DWS | 56,976 | 0 | 0 | 0 | For |
| ProShares | 45,515 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 45,316 | 0 | 0 | 0 | For |
| T. Rowe Price | 40,735 | 0 | 0 | 0 | For |
| Jackson National | 39,351 | 0 | 0 | 0 | For |
| John Hancock | 38,986 | 0 | 0 | 0 | For |
| Voya | 35,519 | 0 | 0 | 0 | For |
| Calvert | 33,733 | 0 | 0 | 0 | For |
| Federated Hermes | 32,750 | 0 | 0 | 0 | For |
Fund voting reports, all 42 managers: 33,448,947 for, 926 against, 17 abstained. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 11,160,407 | 0 | 0 | 0 | For |
| Charles Schwab | 5,309,494 | 0 | 0 | 0 | For |
| State Street | 4,327,709 | 0 | 0 | 0 | For |
| Vanguard | 3,359,481 | 0 | 0 | 0 | For |
| Northern Trust | 2,090,639 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 1,755,422 | 0 | 0 | 0 | For |
| Nuveen | 822,625 | 0 | 0 | 0 | For |
| GMT CAPITAL CORP | 701,600 | 0 | 0 | 0 | For |
| UBS | 0 | 562,736 | 0 | 0 | Against |
| MELLON INVESTMENTS Corp | 540,896 | 0 | 0 | 0 | For |
| T. Rowe Price | 505,468 | 0 | 0 | 0 | For |
| AllianceBernstein | 398,800 | 0 | 0 | 0 | For |
| Goldman Sachs | 273,709 | 0 | 0 | 0 | For |
| FRANKLIN ADVISERS INC | 247,854 | 0 | 0 | 0 | For |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 226,408 | 0 | 0 | 0 | For |
| Invesco | 213,127 | 0 | 0 | 0 | For |
| Allianz | 0 | 198,166 | 0 | 0 | Against |
| Dimensional | 171,785 | 0 | 0 | 0 | For |
| JPMorgan | 166,099 | 0 | 0 | 0 | For |
| NEW YORK STATE COMMON RETIREMENT FUND | 127,800 | 0 | 0 | 0 | For |
| Arizona State Retirement System | 116,547 | 0 | 0 | 0 | For |
| Legal & General Investment Management Ltd | 0 | 102,082 | 0 | 0 | Against |
| PNC BANK, NATIONAL ASSOCIATION | 100,159 | 0 | 0 | 0 | For |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | 98,787 | 0 | 0 | 0 | For |
| BLAIR WILLIAM & CO/IL | 94,500 | 0 | 0 | 0 | For |
Institutional-manager reports, all 139 managers: 34,082,829 for, 937,610 against, 4,191 abstained, 127 not voted. Showing the 25 largest; every one is in the interactive database (link above).
99.8% Approved · of votes cast
Prior year: 99.7% for (June 10, 2025 meeting) ▲ 0.1 pts
Description as filed by funds: THE RATIFICATION OF THE APPOINTMENT OF ERNST & YOUNG LLP AS THE COMPANY'S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM.
Clover Health Investments, Corp.’s own tally for this item (“3. Ratification of the appointment of Ernst & Young LLP as independent registered public accounting firm for the fiscal year ending December 31, 2026”): 1,188,467,663 for, 2,471,606 against — passed, per its Form 8-K filed June 12, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The stockholders ratified the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026.”
Support: 99.8% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 44 asset managers below reported 33,450,094 for, 6 against, 3 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 20,516,673 | 6 | 3 | 0 | For |
| Charles Schwab | 5,306,421 | 0 | 0 | 0 | For |
| BlackRock | 2,548,826 | 0 | 0 | 0 | For |
| Fidelity | 1,175,087 | 0 | 0 | 0 | For |
| Equitable | 832,293 | 0 | 0 | 0 | For |
| TIAA | 733,924 | 0 | 0 | 0 | For |
| Lincoln Financial | 526,054 | 0 | 0 | 0 | For |
| Global X | 335,678 | 0 | 0 | 0 | For |
| Northern Trust | 182,989 | 0 | 0 | 0 | For |
| State Street | 159,804 | 0 | 0 | 0 | For |
| JPMorgan | 145,408 | 0 | 0 | 0 | For |
| Pacific Life | 138,183 | 0 | 0 | 0 | For |
| Lazard | 100,917 | 0 | 0 | 0 | For |
| Dimensional | 79,573 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 78,341 | 0 | 0 | 0 | For |
| SEI | 60,200 | 0 | 0 | 0 | For |
| DWS | 56,976 | 0 | 0 | 0 | For |
| ProShares | 45,515 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 45,316 | 0 | 0 | 0 | For |
| T. Rowe Price | 40,735 | 0 | 0 | 0 | For |
| Jackson National | 39,351 | 0 | 0 | 0 | For |
| John Hancock | 38,986 | 0 | 0 | 0 | For |
| Voya | 35,519 | 0 | 0 | 0 | For |
| Calvert | 33,733 | 0 | 0 | 0 | For |
| Federated Hermes | 32,750 | 0 | 0 | 0 | For |
Showing the 25 largest of 44 asset managers. All 44 are in the interactive database (link above).
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 522,184,385 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 3.93% |
| 2 | Charles Schwab | 1.02% |
| 3 | BlackRock | 0.49% |
| 4 | Fidelity | 0.23% |
| 5 | Equitable | 0.16% |
| 6 | TIAA | 0.14% |
| 7 | Lincoln Financial | 0.10% |
| 8 | Global X | 0.06% |
| 9 | Northern Trust | 0.04% |
| 10 | State Street | 0.03% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | BlackRock | 2.14% |
| 2 | Charles Schwab | 1.02% |
| 3 | State Street | 0.83% |
| 4 | Vanguard | 0.64% |
| 5 | Northern Trust | 0.40% |
| 6 | GEODE CAPITAL MANAGEMENT, LLC | 0.34% |
| 7 | Nuveen | 0.16% |
| 8 | GMT CAPITAL CORP | 0.13% |
| 9 | UBS | 0.11% |
| 10 | MELLON INVESTMENTS Corp | 0.10% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.
| Holder | Shares | % outstanding | Source, as of |
|---|---|---|---|
| Entities affiliated with Vivek Garipalli | 83,584,543 | 16.01% | Proxy statement (DEF 14A), table as of December 31, 2025 |
| BlackRock | 31,840,512 | 6.10% | Form 13F, quarter ended March 31, 2026 |
| Vanguard Group | 23,485,912 | 4.50% | Form 13F, quarter ended March 31, 2026 |
| Geode Capital | 10,055,510 | 1.93% | Form 13F, quarter ended March 31, 2026 |
| State Street | 9,559,889 | 1.83% | Form 13F, quarter ended March 31, 2026 |
| Andrew Toy | 6,235,090 | 1.19% | Proxy statement (DEF 14A), table as of December 31, 2025 |
| Charles Schwab | 5,300,475 | 1.02% | Form 13F, quarter ended March 31, 2026 |
| Dimensional Fund Advisors | 3,417,866 | 0.65% | Form 13F, quarter ended March 31, 2026 |
| Renaissance Technologies | 3,401,541 | 0.65% | Form 13F, quarter ended March 31, 2026 |
| Citadel Advisors | 3,356,248 | 0.64% | Form 13F, quarter ended March 31, 2026 |
Percentages above are of 522,184,385 shares outstanding, as reported by Clover Health Investments, Corp. on its Form 10-Q dated March 31, 2026 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
At Clover Health Investments, Corp.'s shareholder meeting held June 10, 2026, in the 2025-2026 proxy season, 163 asset managers reported votes on at least one of its 5 ballot items in their SEC Form N-PX filings, covering 845 separate fund positions. On the most widely held item on that ballot — Non-binding advisory proposal to approve the compensation paid to our named executive officers… — FOR was 99.0% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: Clover Health Investments, Corp.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 12, 2026.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Clover Health Investments, Corp.’s 10-Q dated March 31, 2026. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.
Clover Health Investments, Corp. proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).
Proxy Votes Now, “Clover Health Investments (CLOV) 2026 Annual Meeting: Vote Results”, https://proxyvotesnow.com/company/clover-health-investments-corp/2026 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.